603139 Stock Overview
Engages in the research and development, production, and sale of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Shaanxi Kanghui Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.80 |
| 52 Week High | CN¥19.79 |
| 52 Week Low | CN¥8.81 |
| Beta | 0.19 |
| 1 Month Change | 5.05% |
| 3 Month Change | 37.27% |
| 1 Year Change | -16.84% |
| 3 Year Change | -24.98% |
| 5 Year Change | -5.84% |
| Change since IPO | -24.69% |
Recent News & Updates
Insufficient Growth At Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Hampers Share Price
Sep 30
Market Cool On Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues Pushing Shares 28% Lower
Jun 09Recent updates
Insufficient Growth At Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Hampers Share Price
Sep 30Market Cool On Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues Pushing Shares 28% Lower
Jun 09Little Excitement Around Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues
Feb 27Shareholder Returns
| 603139 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.7% | -1.9% | -1.2% |
| 1Y | -16.8% | -1.8% | 11.8% |
Return vs Industry: 603139 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 603139 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 603139 volatility | |
|---|---|
| 603139 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603139 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603139's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 952 | Yanling Wang | www.sxkh.com |
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company was founded in 2009 and is based in Xianyang, China.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Fundamentals Summary
| 603139 fundamental statistics | |
|---|---|
| Market cap | CN¥1.58b |
| Earnings (TTM) | -CN¥73.67m |
| Revenue (TTM) | CN¥605.28m |
2.6x
P/S Ratio-21.4x
P/E RatioIs 603139 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603139 income statement (TTM) | |
|---|---|
| Revenue | CN¥605.28m |
| Cost of Revenue | CN¥430.40m |
| Gross Profit | CN¥174.87m |
| Other Expenses | CN¥248.54m |
| Earnings | -CN¥73.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.74 |
| Gross Margin | 28.89% |
| Net Profit Margin | -12.17% |
| Debt/Equity Ratio | 71.4% |
How did 603139 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 12:05 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shaanxi Kanghui Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiaxi Xu | Industrial Securities Co. Ltd. |